Drug Markets/Fluticasone Propionate and Salmeterol

Fluticasone Propionate and Salmeterol

23 NDCs across 6 manufacturers|15 Generic,8 Brand

▸ More about this market

Fluticasone Propionate and Salmeterol is available as 23 NDCs from 6 manufacturers (15 generic, 8 brand), with NADAC prices from $1.07 to $385.98 per EA — the most expensive product costs about 360× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

15G / 8B

Manufacturers

competing in market

Price Spread

$1.07 – $385.98

per EA

7d Activity

8↑26↓-13 flat

avg -1.7% WoW · of 23 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Top supplier

Teva Pharmaceuticals USA Inc. manufacturer profile

Open the supplier page for the manufacturer with the strongest footprint in this market.

Lead class

Corticosteroid class view

See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.

Trend hub

Latest market trends

Move from this single molecule into the current cross-market mover and volatility view.

Guide

How to interpret NADAC

Review the benchmark methodology behind the prices and spreads shown on this market page.

Manufacturer Breakdown

6 manufacturers producing FLUTICASONE PROPIONATE AND SALMETEROL(1 pricing outlier)

Teva Pharmaceuticals USA Inc.

Mylan Pharmaceuticals Inc.

3 NDCs

$1.3183

avg/unit

Hikma Pharmaceuticals USA Inc.

Teva Respiratory, LLC

Drug Portfolio

23 NDCs total, 23 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
AIRDUO RESPICLICK 113-14 MCG	59310081206	Teva Respiratory, LLC	$385.9814 per EA	High Outlier	Brand	—	Corticosteroid, beta2-Adrenergic Agonist
AIRDUO RESPICLICK 232-14 MCG	59310082206	Teva Respiratory, LLC	$385.1574 per EA	High Outlier	Brand	—	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 55-14	00093360782	Teva Pharmaceuticals USA Inc.	$114.8490 per EA	—	Generic	+0.93%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 113-14	00093360882	Teva Pharmaceuticals USA Inc.	$108.2789 per EA	—	Generic	-2.90%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 232-14	00093360982	Teva Pharmaceuticals USA Inc.	$105.3214 per EA	—	Generic	+1.69%	Corticosteroid, beta2-Adrenergic Agonist
ADVAIR 500-50 DISKUS	00173069704	GlaxoSmithKline LLC	$16.9172 per EA	—	Brand	—	Corticosteroid, beta2-Adrenergic Agonist
ADVAIR 100-50 DISKUS	00173069504	GlaxoSmithKline LLC	$10.3780 per EA	—	Brand	—	Corticosteroid, beta2-Adrenergic Agonist
ADVAIR 500-50 DISKUS	00173069700	GlaxoSmithKline LLC	$4.2281 per EA	—	Brand	+0.02%	Corticosteroid, beta2-Adrenergic Agonist
ADVAIR 250-50 DISKUS	00173069600	GlaxoSmithKline LLC	$3.1227 per EA	—	Brand	0.00%	Corticosteroid, beta2-Adrenergic Agonist
ADVAIR 250-50 DISKUS	00173069604	GlaxoSmithKline LLC	$3.1083 per EA	—	Brand	—	Corticosteroid, beta2-Adrenergic Agonist
ADVAIR 100-50 DISKUS	00173069500	GlaxoSmithKline LLC	$2.4867 per EA	—	Brand	+0.02%	Corticosteroid, beta2-Adrenergic Agonist
WIXELA 500-50 INHUB	00378932232	Mylan Pharmaceuticals Inc.	$1.6362 per EA	—	Generic	-0.80%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 500-50	00054032856	Hikma Pharmaceuticals USA Inc.	$1.6362 per EA	—	Generic	-0.80%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 500-50	66993058697	Prasco Laboratories	$1.6362 per EA	—	Generic	-0.80%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 500-50	00093751631	Teva Pharmaceuticals USA Inc.	$1.6362 per EA	—	Generic	-0.80%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 250-50	00093751831	Teva Pharmaceuticals USA Inc.	$1.2451 per EA	—	Generic	-2.61%	Corticosteroid, beta2-Adrenergic Agonist
WIXELA 250-50 INHUB	00378932132	Mylan Pharmaceuticals Inc.	$1.2451 per EA	—	Generic	-2.61%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 250-50	66993058597	Prasco Laboratories	$1.2451 per EA	—	Generic	-2.61%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 250-50	00054032756	Hikma Pharmaceuticals USA Inc.	$1.2451 per EA	—	Generic	-2.61%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 100-50	00093751731	Teva Pharmaceuticals USA Inc.	$1.0736 per EA	—	Generic	-4.04%	Corticosteroid, beta2-Adrenergic Agonist
WIXELA 100-50 INHUB	00378932032	Mylan Pharmaceuticals Inc.	$1.0736 per EA	—	Generic	-4.04%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 100-50	00054032656	Hikma Pharmaceuticals USA Inc.	$1.0736 per EA	—	Generic	-4.04%	Corticosteroid, beta2-Adrenergic Agonist
FLUTICASONE-SALMETEROL 100-50	66993058497	Prasco Laboratories	$1.0736 per EA	—	Generic	-4.04%	Corticosteroid, beta2-Adrenergic Agonist

Frequently Asked Questions

How many Fluticasone Propionate and Salmeterol products are on the market?

The Fluticasone Propionate and Salmeterol drug market contains 23 NDCs from 6 manufacturers — 15 generic and 8 brand products.

What is the price range for Fluticasone Propionate and Salmeterol?

NADAC reference prices for Fluticasone Propionate and Salmeterol range from $1.0736 to $385.9814 per EA — the most expensive product costs about 360× the cheapest.

Is generic Fluticasone Propionate and Salmeterol cheaper than brand?

The average generic NADAC for Fluticasone Propionate and Salmeterol is $22.9513 per EA, versus $101.4225 for brand-labeled products — brand versions average about 4.4× the generic price.

Which manufacturers make Fluticasone Propionate and Salmeterol?

6 manufacturers list Fluticasone Propionate and Salmeterol in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (6), GlaxoSmithKline LLC (6), Mylan Pharmaceuticals Inc. (3), Hikma Pharmaceuticals USA Inc. (3), Prasco Laboratories (3).

How has the price of Fluticasone Propionate and Salmeterol changed recently?

Over the past 7 days, 8 Fluticasone Propionate and Salmeterol NDCs rose and 26 fell, with a market-wide average change of -1.7%.